Latest news

Thumbnail image for Deliver on your potential

Deliver on your potential

Highlighting the real difference that individual sales people can deliver to both patients and HCP’s, the PharmaTimes Sales Awards offers a crucial opportunity for learning and development against an ever changing landscape.

27th July 2018

Thumbnail image for NICE backing for Keytruda in classical Hodgkin lymphoma

NICE backing for Keytruda in classical Hodgkin lymphoma

The National Institute for Health and Care Excellence has recommended that MSD’s Keytruda be funded on the NHS via the Cancer Drugs Fund (CDF) for a subgroup of people with relapsed or refractory classical Hodgkin lymphoma.

26th July 2018

Thumbnail image for Time is running out - ENTER NOW

Time is running out - ENTER NOW

The prestigious PharmaTimes Marketer of the Year competition closes for entries in a matter of weeks. It only takes a few seconds to fill out the online entry form and you don’t need to do anything else until the day of the competition, so if you are thinking of entering, do it now!

25th July 2018

Thumbnail image for GSK ups guidance and unveils major restructure

GSK ups guidance and unveils major restructure

GlaxoSmithKline has upped its expectations for the year after a strong performance by its vaccines division in the second quarter and the delay of a potential generic version of Advair in the US.

25th July 2018

Thumbnail image for ViiV unveils positive data for two-drug HIV regimens

ViiV unveils positive data for two-drug HIV regimens

ViiV Healthcare has unveiled positive clinical data for two two-drug HIV regimens ay the 22nd International AIDS conference in Amsterdam, showing long-term efficacy and non-inferiority to a current standard of care.

25th July 2018

Thumbnail image for US approves AbbVie/Neurocrine’s uterine pain drug

US approves AbbVie/Neurocrine’s uterine pain drug

AbbVie and Neurocrine have announced the US approval of Orilissa, the first and only oral gonadotropin-releasing hormone (GnRH) antagonist specifically developed for women with moderate to severe endometriosis pain.

25th July 2018

Previous  --   8 9 10 11 12 13 14 15 16 17   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download